put Our Experience to work for you
Expand the reach of your studies and find the right population using our global experience to help inform your portfolio and feasibility decisions.
we have a worldwide presence
Click on a highlighted country, state or pin to see details of our experience in that area, or to see our reach for a specific therapeutic area, select it from the dropdown menu.
Data current as of January 1, 2022. The boundaries and names on this map do not imply official endorsement or acceptance by FHI Clinical.

FHI Clinical Presence

FHI Clinical & FHI 360

FHI 360 Locations
We are localized
We know how to navigate location-specific challenges so you can be prepared for any circumstance regardless of study location.
FHI Clinical has the local resources and experience to keep your study moving forward: engage with the local communities, work with still-developing regulatory agencies, ramp up quickly for an outbreak, implement contingency plans for natural disasters or political unrest and more.

Successfully implementing studies in complex settings requires an understanding of and respect for the local communities.
Our far-reaching, in-country technical, regulatory and cultural knowledge has been developed over our long history of working globally.
Our experience helps us guide decisions about the best-fit countries and populations for your target indication.
africa

Geographic Coverage
We’ve been involved in observational studies, behavioral studies and clinical trials for epidemiology, spatial repellents, vaccines and treatments in 26 African countries.

Local Resources
FHI 360 or FHI Clinical offices and resources are located in 23 countries throughout Africa.

Priority Indications
Our research involvement has included COVID-19, Ebola, gastroenteritis, rotavirus gastroenteritis, malaria, malnutrition, meningitis, onchocerciasis, pneumonia, streptococcus pneumoniae, HIV, tuberculosis and HIV/tuberculosis co-infection.
Asia Pacific

Geographic Coverage
We’ve been involved in observational and clinical trials for epidemiology, diagnostic tests, vaccines and disease treatment in 11 Asia Pacific countries.

Local Resources
FHI 360 or FHI Clinical offices and resources are located in 12 countries throughout Asia Pacific.

Priority Indications
Our research involvement has included COVID-19, Avian influenza, influenza, dengue, pneumonia, HPV, Japanese encephalitis, lymphatic filariasis, rotavirus gastroenteritis, sepsis, malaria, tuberculosis and HIV/tuberculosis co-infection.
Europe

Geographic Coverage

Local Resources

Priority Indications
latin america and the caribbean

Geographic Coverage

Local Resources
FHI 360 or FHI Clinical offices and resources are located in nine countries throughout Latin America and the Caribbean.

Priority Indications
Our involvement in clinical trials has included COVID-19, Chikungunya, Zika, malaria and HIV/tuberculosis co-infection.
North America

Geographic Coverage

Local Resources

Priority Indications
we are globally connected
Access the skill sets necessary to quickly and efficiently combat disease.
Sustainable relationships with key partners ensure proactive disease management as well as rapid responses to immediate needs.
Reducing the global disease burden is only possible when we pool our resources and skills. We have collaborative partnerships with:
- Leading public and private medical research organizations
- Pharmaceutical and biotechnology companies
- Academic institutions
- United States National Institutes of Health (NIH)
- United States Centers for Disease Control and Prevention (CDC)
- United States Agency for International Development (USAID)
- Consultative partners
- World-renowned physicians and scientists
- Field-established thought leaders in multiple therapeutic areas
- Subject matter experts in regulatory authority guidance and support
- Experts in infectious diseases, tuberculosis, maternal and child health, family planning, HIV/AIDS and other sexually transmitted infections
Participation in research networks
WE SUPPORT MANY THERAPEUTIC AREAS
Leverage our expertise to address challenges across many therapeutic areas in both adult and pediatric populations:
SPECIFIC INFECTIOUS DISEASE EXPERTISE
Our team is particularly passionate about addressing infectious diseases, neglected tropical diseases and emerging and reemerging diseases in vulnerable populations: